US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 7.310
  • 0.0000.00%
Close Apr 22 16:00 ET
  • 7.500
  • +0.190+2.60%
Post 17:54 ET
780.11MMarket Cap-6768P/E (TTM)

Tango Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
1.96%6.92M
-68.21%5.77M
-9.83%5.76M
Operating revenue
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
1.96%6.92M
-68.21%5.77M
-9.83%5.76M
Cost of revenue
Gross profit
Operating expense
10.87%150.7M
9.37%40.44M
-1.32%36.36M
22.19%37.85M
15.79%36.05M
42.74%135.93M
33.49%36.98M
39.79%36.84M
36.39%30.97M
68.61%31.14M
Selling and administrative expenses
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
82.70%8.1M
99.23%7.23M
96.34%6.81M
-General and administrative expense
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
82.70%8.1M
99.23%7.23M
96.34%6.81M
Research and development costs
8.77%115.2M
7.73%31.34M
-5.55%27.15M
20.77%28.67M
15.24%28.04M
36.41%105.91M
34.47%29.09M
31.11%28.74M
24.44%23.74M
62.20%24.33M
Operating profit
-2.79%-114.17M
-14.55%-35.01M
14.36%-25.63M
7.76%-23.25M
-19.33%-30.29M
-90.88%-111.07M
-39.04%-30.57M
-52.91%-29.92M
-453.16%-25.2M
-110.07%-25.38M
Net non-operating interest income expense
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
284.62%350K
185.58%297K
109.62%218K
Non-operating interest income
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
284.62%350K
185.58%297K
109.62%218K
Other net income (expense)
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
1,146.00%523K
180.65%50K
14.55%-47K
Other non- operating income (expenses)
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
1,146.00%523K
180.65%50K
14.55%-47K
Income before tax
6.02%-101.61M
-5.88%-30.72M
23.44%-22.24M
16.93%-20.65M
-11.11%-28.01M
-86.60%-108.12M
-32.65%-29.01M
-48.76%-29.05M
-450.62%-24.86M
-109.51%-25.21M
Income tax
148.15%134K
-7.84%47K
23K
2,033.33%64K
-81.51%54K
-71.19%51K
0
114.29%3K
Net income
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
-453.26%-24.86M
-108.23%-25.21M
Net income continuous Operations
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
-453.26%-24.86M
-108.23%-25.21M
Minority interest income
Net income attributable to the parent company
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
-453.26%-24.86M
-108.23%-25.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
-453.26%-24.86M
-108.23%-25.21M
Basic earnings per share
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
-17.86%-0.33
-445.13%-0.28
-109.55%-0.29
Diluted earnings per share
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
-17.86%-0.33
-445.13%-0.28
-109.55%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M1.96%6.92M-68.21%5.77M-9.83%5.76M
Operating revenue 46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M1.96%6.92M-68.21%5.77M-9.83%5.76M
Cost of revenue
Gross profit
Operating expense 10.87%150.7M9.37%40.44M-1.32%36.36M22.19%37.85M15.79%36.05M42.74%135.93M33.49%36.98M39.79%36.84M36.39%30.97M68.61%31.14M
Selling and administrative expenses 18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M82.70%8.1M99.23%7.23M96.34%6.81M
-General and administrative expense 18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M82.70%8.1M99.23%7.23M96.34%6.81M
Research and development costs 8.77%115.2M7.73%31.34M-5.55%27.15M20.77%28.67M15.24%28.04M36.41%105.91M34.47%29.09M31.11%28.74M24.44%23.74M62.20%24.33M
Operating profit -2.79%-114.17M-14.55%-35.01M14.36%-25.63M7.76%-23.25M-19.33%-30.29M-90.88%-111.07M-39.04%-30.57M-52.91%-29.92M-453.16%-25.2M-110.07%-25.38M
Net non-operating interest income expense 354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K284.62%350K185.58%297K109.62%218K
Non-operating interest income 354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K284.62%350K185.58%297K109.62%218K
Other net income (expense) 298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K1,146.00%523K180.65%50K14.55%-47K
Other non- operating income (expenses) 298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K1,146.00%523K180.65%50K14.55%-47K
Income before tax 6.02%-101.61M-5.88%-30.72M23.44%-22.24M16.93%-20.65M-11.11%-28.01M-86.60%-108.12M-32.65%-29.01M-48.76%-29.05M-450.62%-24.86M-109.51%-25.21M
Income tax 148.15%134K-7.84%47K23K2,033.33%64K-81.51%54K-71.19%51K0114.29%3K
Net income 5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M-453.26%-24.86M-108.23%-25.21M
Net income continuous Operations 5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M-453.26%-24.86M-108.23%-25.21M
Minority interest income
Net income attributable to the parent company 5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M-453.26%-24.86M-108.23%-25.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M-453.26%-24.86M-108.23%-25.21M
Basic earnings per share 12.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33-17.86%-0.33-445.13%-0.28-109.55%-0.29
Diluted earnings per share 12.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33-17.86%-0.33-445.13%-0.28-109.55%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg